Beware of the heart: The multiple picture of cardiac involvement in myositis

Rheumatology

Volumn 38, Issue 11, 1999, Pages 1153-1157

  Riemekasten, G ^a,b   Opitz, C ^a   Audring, H ^a   Barthelmes, H ^a   Meyer, R ^a   Hiepe, F ^a   Burmester, G R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Dept Rheumatology Clin Immunol ^*  (Germany)

Author keywords

Case report; Dermatomyositis; Prinzmetal's angina; Raynaud's phenomenon; Small vessel disease

Indexed keywords

ACETYLCHOLINE; CALCIUM CHANNEL BLOCKING AGENT; NEUROPEPTIDE;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; FEMALE; HEART INFARCTION; HEART MUSCLE BIOPSY; HUMAN; LUNG EDEMA; PRIORITY JOURNAL; PROVOCATION TEST; RAYNAUD PHENOMENON; THORAX PAIN; VASOCONSTRICTION;

EID: 0032719265     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.11.1153     Document Type: Article

References (19)

1. Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, Rosas E, Suarez-Almazor M, Cardona-Munoz E et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 1996;14:373-9.
2. Taylor AJ, Wortham DC, Burge JR, Rogan KM. The heart in polymyositis: a prospective evaluation in 26 patients. Clin Cardiol 1993;16:802-8.
3. Denbow CE, Lie T, Trancredi RG, Bunch TW. Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 1979;22:1088-92.
4. Brottier L, Coste P, Combe C, Bruchere C, Bonnet J, Bricaud H. Cardiac complications of dermatopolymyositis. Arch Mal Coeur Vaiss 1987;80:1133-8.
5. Murabayashi, K, Saito, E, Okada, S, Ogawa, T, Kinoshita, M. Prognosis of life in polymyositis/dermatomyositis. Ryumachi 1991;31:391-7.
6. Schwarz MI. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging 1992; 7:46-54.
7. Iannone F, Cauli A, Yanni G, Kingsley GH, Isenberg DA, Corrigall V et al. T-Lymphocyte immunophenotyping in polymyositis and dermatomyositis. Br J Rheumatol 1996;35:839-45.
8. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-96.
9. Askari AD. Cardiac abnormalities. Clin Rheum Dis 1984;10:131-49.
10. Peng SK, French WJ. Morphological changes in small vessels on endomyocardial biopsies. Ann Clin Lab Sei 1986;16:180-8.
11. Botker HE, Sonne HS, Sorensen KE. Frequency of systemic microvascular dysfunction in syndrome X and in variant angina. Am J Cardiol 1996;78:182-6.
12. Ho M, Belch JJF. Raynaud's phenomenon: state of the art 1998. Scand J Rheumatol 1998;27:319-22.
13. Generini S, Kahaleh B, Matucci-Cerinic M, Pignone A, Lombardi A, Ohtzuka T. Raynaud's phenomenon and systemic sclerosis. Ann Ital Med Int 1996;11:125-31.
14. Kahaleh B, Matucci-Cerinic M. Raynaud's phenomenon and scleroderma. Arthritis Rheum 1995;38:1-4.
15. Khan F, Litchfiel SJ, McLaren M, Veale DJ, Littleford RC, Belch JJF. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum 1997;40:352-7.
16. Valter I, Maricq HR. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, Southern Estonia. Scand J Rheumatol 1997;26:117-24.
17. Matsunaga T, Tsunoda R. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol 1996;27:45-52.
18. Fukai T, Koyanagi S, Takeshita A. Role of coronary vasospasm in the pathogenesis of myocardial infarction: study in patients with no significant coronary stenosis. Am Heart J 1993;126:1305-11.
19. Strauer BE, Schwartzkopf B, Motz W, Vogt M. Coronary vascular changes in the progression and regression of hypertensive heart disease. J Cardiovasc Pharmacol 1991;18:20-7.